# Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone

> **NCT00563017** · NA · UNKNOWN · sponsor: **Hospital Authority, Hong Kong** · enrollment: 30 (estimated)

## Conditions studied

- Schizophrenia, Catatonic
- Schizophrenia, Disorganized
- Schizophrenia, Paranoid
- Schizophrenia
- Psychotic Disorders

## Interventions

- **DRUG:** Long-acting Risperidone microspheres injection

## Key facts

- **NCT ID:** NCT00563017
- **Lead sponsor:** Hospital Authority, Hong Kong
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00563017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00563017, "Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00563017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*